By Patrick Wingrove and Sriparna Roy Oct 29 (Reuters) – Eli Lilly raised its full-year revenue forecast and beat third-quarter profit estimates on Thursday, as booming demand for its injectable
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)